What are Aptamers?
Aptamers are single-stranded DNA or RNA molecules obtained through in vitro selection techniques (such as SELEX) from synthetic, randomized nucleic acid libraries. They can bind to target molecules (such as proteins, small molecules, cells, etc.) with high affinity and specificity through unique three-dimensional structures, earning them the titles “chemical antibodies” or “nucleic acid antibodies.”
Chemical Nature
Mostly single-stranded DNA or RNA, producible via chemical synthesis, offering good stability and ease of modification or labeling.
Binding Mechanism
Form hydrogen bonds, electrostatic interactions, etc., through spatial conformations (e.g., hairpins, pockets, bulges) to recognize targets with atomic-level precision.
High Affinity & Specificity
Capable of distinguishing structurally similar molecules (e.g., caffeine vs. theophylline), with dissociation constants (Kd) reaching nanomolar (nM) or even picomolar (pM) levels.
Strong Stability
Resistant to high temperatures, reversible denaturation, and less susceptible to damage in acidic/basic environments (especially DNA aptamers), making them suitable for complex applications.
| Feature | Aptamers | Antibodies (Traditional Protein Antibodies) |
|---|---|---|
| Production Time | In vitro selection (weeks), chemical synthesis, high batch consistency | Animal immunization or cell culture (months), significant batch variability |
| Stability | Heat-resistant, easy storage, transportable at room temperature | Prone to denaturation, requires cold storage |
| Modification Flexibility | Easy labeling with fluorescent dyes, isotopes, etc. | Modifications may affect structure |
| Immunogenicity | Generally non-immunogenic, low toxicity | May trigger immune reactions |
| Target Range | Targets range from ions to whole cells, even toxic molecules | Typically limited to immunogenic molecules |
Disease Diagnosis
Serve as recognition elements in biosensors (e.g., electrochemical, fluorescent sensors) to detect disease biomarkers (e.g., cancer proteins, viral antigens).
Used in point-of-care testing (POCT) devices, such as COVID-19 test strips.
Targeted Therapy
As drug carriers: Conjugated with chemotherapy drugs or nucleic acid therapeutics for precise delivery (e.g., the approved drug Macugen for age-related macular degeneration).
Direct inhibitors: Block pathogen proteins or cancer cell signaling pathways.
Cellular Imaging
Fluorescently labeled aptamers for in vivo or cellular imaging to track target distribution.
Food Safety & Environmental Monitoring
Detect toxins (e.g., aflatoxins), antibiotic residues, or pollutants.
Basic Research Tools
Used in protein function studies, cell sorting, etc.
SELEX (Systematic Evolution of Ligands by Exponential Enrichment) is the core method for aptamer selection:
Construct a nucleic acid library with 10¹³–10¹⁵ random sequences;
Incubate with the target and wash away unbound sequences;
Recover specifically bound sequences and amplify them via PCR;
Repeat for multiple rounds (typically 8–15) to enrich high-affinity sequences.
Modern SELEX variants include cell-SELEX, automated microfluidic SELEX, etc.
Challenges:
Susceptibility to nuclease degradation (especially RNA aptamers; improvable via chemical modifications);
Complex in vivo environments may affect conformation; high costs for large-scale production.
Future Directions:
Developing more stable locked nucleic acid (LNA) or peptide nucleic acid (PNA) aptamers;
AI-assisted design to shorten selection cycles;
Integrating nanotechnology for multifunctional diagnostic/therapeutic platforms.
As molecular recognition tools, aptamers are increasingly demonstrating potential to replace or complement traditional antibodies in fields like precision medicine and detection technology, making them a research hotspot at the intersection of chemical biology and nanomedicine.
Aptamer Screening Service-Multi-Round SELEX Screening
Aptamer Screening Service-HT-SELEX
Aptamer Screening Service-NGS-SELEX
Aptamer Screening Service-Counter SELEX
Aptamer Screening Service-Subtractive SELEX
Aptamer Therapeutics
Aptamers as therapeutics
Aptamer Identification
Are there any FDA approved aptamer drugs?
What is the difference between an antibody and an aptamer?
What is aptamer used for?
APPLICATION OF APTAMERS IN TARGETED THERAPY OF LIVER CANCER
Toggle-SELEX Aptamer Screening Service
Negative Aptamer Selection- A Practical Guide to Improving Aptamer Specificity in SELEX
selexkmdbio-Cell Nucleic Acid Aptamer Screening Service
Aptamer Screening- Current Methods and Future Trend towards Non-SELEX Approach
Aptamer Screening Service-Subtractive SELEX
Aptamer Screening Service-Counter SELEX
Aptamer Screening Service-HT-SELEX
Aptamer Screening Service-NGS-SELEX
Aptamer Screening Service-Multi-Round SELEX Screening
Whole Cell-SELEX Aptamer Screening Service
Membrane Protein Aptamer Screening Service
Aptamer Screening Service for Drug Discovery
Aptamer Live Cell SELEX Service
Classical SELEX Service for Aptamer
Aptamer Selection and Identification
Aptamer Screening Process and Applications Overview